Ameritas Investment Partners’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.2K | Buy |
9,582
+955
| +11% | +$9.09K | ﹤0.01% | 1819 |
|
|
2025
Q1 | $90.2K | Hold |
8,627
| – | – | ﹤0.01% | 1776 |
|
|
2024
Q4 | $203K | Buy |
8,627
+721
| +9% | +$17K | 0.01% | 1313 |
|
|
2024
Q3 | $284K | Hold |
7,906
| – | – | 0.01% | 1111 |
|
|
2024
Q2 | $279K | Buy |
7,906
+2,010
| +34% | +$70.9K | 0.01% | 1051 |
|
|
2024
Q1 | $167K | Buy |
5,896
+1,291
| +28% | +$36.7K | 0.01% | 1410 |
|
|
2023
Q4 | $61.2K | Buy |
4,605
+1,095
| +31% | +$14.6K | ﹤0.01% | 2044 |
|
|
2023
Q3 | $31.5K | Hold |
3,510
| – | – | ﹤0.01% | 2332 |
|
|
2023
Q2 | $39.5K | Buy |
3,510
+1,155
| +49% | +$13K | ﹤0.01% | 2188 |
|
|
2023
Q1 | $27.1K | Hold |
2,355
| – | – | ﹤0.01% | 2334 |
|
|
2022
Q4 | $32.1K | Hold |
2,355
| – | – | ﹤0.01% | 2323 |
|
|
2022
Q3 | $29K | Hold |
2,355
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q2 | $16K | Hold |
2,355
| – | – | ﹤0.01% | 2647 |
|
|
2022
Q1 | $23K | Hold |
2,355
| – | – | ﹤0.01% | 2489 |
|
|
2021
Q4 | $28K | Hold |
2,355
| – | – | ﹤0.01% | 2476 |
|
|
2021
Q3 | $38K | Hold |
2,355
| – | – | ﹤0.01% | 2336 |
|
|
2021
Q2 | $50K | Buy |
2,355
+1,163
| +98% | +$24.7K | ﹤0.01% | 2179 |
|
|
2021
Q1 | $19K | Hold |
1,192
| – | – | ﹤0.01% | 2585 |
|
|
2020
Q4 | $25K | Buy |
+1,192
| New | +$25K | ﹤0.01% | 2352 |
|